Kwality Pharmaceuticals P/B Ratio
Kwality Pharmaceuticals P/B ratio. Kwality Pharmaceuticals (KPL) P/B ratio is 11.23 (High), book value per share ₹330.00 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. View KPL annual price range for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
KPL P/B Ratio — Valuation Insights & Book Value Analysis
Kwality Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 11.23 (High). For live price, earnings yield and the full fundamental profile, see KPL share price screener.
- Stock appears overvalued with PB of 11.23, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 141.2% above historical average
- Trading at premium to sector average PB of 0.01
Kwality Pharmaceuticals P/B Ratio Historical Trend
KPL annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Analyse KPL shareholding pattern to track promoter, FII and institutional holdings.
KPL Historical P/B Ratio — Book Value Per Share & Year-End Price
Kwality Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 11.04 | ₹330.0 | ₹3644.20 | ₹330 | High |
| 2025 | 4.23 | ₹262.0 | ₹1108.35 | ₹262 | High |
| 2024 | 3.89 | ₹223.0 | ₹866.80 | ₹223 | High |
| 2023 | 2.01 | ₹199.0 | ₹399.80 | ₹199 | Moderate |
| 2022 | 2.11 | ₹180.0 | ₹379.80 | ₹180 | Moderate |
KPL vs Healthcare Peers — P/B Ratio Comparison
Kwality Pharmaceuticals P/B 11.23 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |